• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

2 years ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

CFTC Introduces New Self-Reporting Guidelines for Crypto Firms

chest

The CFTC has released new guidelines aimed at encouraging self-reporting and cooperation among regulated entities, including crypto firms.

user avatarTomas Novak

Ostium Trading Halted Due to Oracle Key Compromise

chest

Ostium has halted trading due to a significant exploit linked to a compromised oracle private key, affecting price feed integrity.

user avatarKaterina Papadopoulou

SEC and CFTC Initiate Joint Consultation to Clarify Crypto Derivatives Regulations

chest

The SEC and CFTC have launched a joint consultation to clarify the regulatory landscape for digital asset derivatives.

user avatarMaya Lundqvist

IREN Stock Rallies Nearly 7% After Securing $2.8 Billion AI Contract

chest

IREN stock surged nearly 7% after securing a $2.8 billion AI contract.

user avatarLeo van der Veen

White House's Ethics Deal Could Propel CLARITY Act Forward

chest

The White House has reached an agreement on an ethics package for the CLARITY Act, potentially paving the way for its passage in the Senate.

user avatarLi Weicheng

Stablecoin Growth on Solana Enhances DeFi and Payment Applications

chest

The growth of stablecoins on Solana is expected to enhance DeFi lending markets and payment applications.

user avatarMohamed Farouk

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.